Royalty Pharma
RPRX
#1153
Rank
C$22.43 B
Marketcap
$37.80
Share price
0.37%
Change (1 day)
0.07%
Change (1 year)

Earnings for Royalty Pharma (RPRX)

Earnings in 2024 (TTM): C$1.63 Billion

According to Royalty Pharma's latest financial reports the company's current earnings are C$2.23 Billion. In 2023 the company made an earning of C$2.63 Billion, an increase over its 2022 earnings that were of C$0.58 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Royalty Pharma from 2019 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) C$1.63 B-38.08%
2023 C$2.63 B351.47%
2022 C$0.58 B-70.3%
2021 C$1.96 B-24.3%
2020 C$2.59 B-31.9%
2019 C$3.80 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
C$49.53 M-97.08%๐Ÿ‡บ๐Ÿ‡ธ USA
C$9.08 B 435.15%๐Ÿ‡บ๐Ÿ‡ธ USA
C$12.54 B 639.07%๐Ÿ‡บ๐Ÿ‡ธ USA